✦ LIBER ✦

Risk of lymphoma in inflammatory bowel disease

✍ Scribed by Edward V Loftus Jr.; William J Tremaine; Thomas M Habermann; W.Scott Harmsen; Alan R Zinsmeister; William J Sandborn

Book ID: 119389101
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 48 KB
Volume: 95
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(00)01108-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of malignant lymphoma in patients w

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose

Sa1277 Incidence, Risk Factors and Clini

Sa1277 Incidence, Risk Factors and Clinical Characteristics of Lymphoma in Korean Patients With Inflammatory Bowel Disease

✍ Soo-kyung Park; Byong Duk Ye; Suk-Kyun Yang; Dong-Hoon Yang; Kee Wook Jung; Kyun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Lymphoma risk in children and young adul

Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort

✍ Lori A. Ashworth; Amy Billett; Paul Mitchell; Federica Nuti; Corey Siegel; Athos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

Sa1247 Low Risk of Lymphoma in Inflammat

Sa1247 Low Risk of Lymphoma in Inflammatory Bowel Diseases in Western Hungary. Results From a Population-Based Incident Cohort

✍ Laszlo Lakatos; Petra A. Golovics; Barbara D. Lovasz; Zsuzsanna Erdelyi; Gabor M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Lymphoma in inflammatory bowel disease

✍ Adrian J. Greenstein; Gerard E. Mullin; James A. Strauchen; Tomas Heimann; Henry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

Lymphoma risk in inflammatory bowel dise

Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?

✍ Jennifer L. Jones; Edward V. Loftus Jr. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

With the increasingly widespread use of immunosuppressive and biologic agents for the treatment of Crohn's disease and ulcerative colitis come concerns about potential long-term consequences of such therapies. Disentangling the potential confounding effects of the underlying disease, its extent, sev